Inventaire - your friends and communities are your best library

Rett Syndrome: Reaching for Clinical Trials

author

Lucas Pozzo-miller

Alan K. Percy

published in: Neurotherapeutics

date of publication: 2015-07-01

language: English

main subject: Rett syndrome, clinical trial

Cites articles 111

Date

Title

Authors

2015-01-29

Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene

Jose A Herrera, Michail Kochukov, Jeffrey L. Neul
2014-09-01

A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome
2014-07-22

Developmental delay in Rett syndrome: data from the natural history study

Jeffrey L. Neul, Alan K. Percy, Walter E Kaufmann, Daniel G Glaze
2014-06-23

Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome

Daniela Tropea, Jeremy Petravicz, Showming Kwok, Mriganka Sur, Nikolaos Mellios
2014-01-01

Brain-derived neurotrophic factor and Rett syndrome
2014-03-12

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

Ingrid A Holm, Walter E Kaufmann
2014-01-07

Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome

Vishnu Anand Cuddapah, Daniel Tarquinio, Michelle L. Olsen, Alan K. Percy, Walter E Kaufmann, Jeffrey L. Neul, Daniel G Glaze
2014-06-01

Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome

Ana Paula Abdala, Julian Paton
2013-04-15

BDNF deregulation in Rett syndrome

Lucas Pozzo-miller
2013-01-01

Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options

Lucas Pozzo-miller, Alan K. Percy
2013-10-01

Assessment and management of nutrition and growth in Rett syndrome

Helen Leonard, Madhur Ravikumara, Gordon Baikie, Alan K. Percy, Jenny Downs
2013-08-01

Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome

Hélène Cheval, James C McGann, Adrian Peter Bird
2013-03-05

Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function

Christopher S. Ward, Andreas Hoeflich, Lucas Pozzo-miller, Jeffrey L. Neul
2013-02-09

Changing the perspective on early development of Rett syndrome

Helen Tager-Flusberg, Peter B Marschik, Jeff Sigafoos, Walter E Kaufmann, Christa Einspieler
2013-01-01

Neurotrophin regulation of neural circuit development and function
2012-12-01

NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.

Piero Carninci
2012-11-01

Preclinical research in Rett syndrome: setting the foundation for translational success

Sacha B. Nelson, James H. Eubanks, Jeffrey L. Neul, Lucas Pozzo-miller, Diana Christian, Maurizio Giustetto, Jacky Guy, Rodney Samaco, Huda Zoghbi
2012-10-01

Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment

Diana Christian
2012-10-03

Growth failure and outcome in Rett syndrome: specific growth references

Daniel Tarquinio, Alan K. Percy, Daniel G Glaze
2012-09-25

Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice

Kamal K E Gadalla, Mark E. S. Bailey
2012-08-13

Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome

Yves-Alain Barde, Rubén Deogracias, Martijn P J Dekkers, Jacky Guy
2012-07-01

The role of oxidative stress in Rett syndrome: an overview

Claudio De Felice, Silvia Leoncini, Lucia Ciccoli, Joussef Hayek, Giuseppe Valacchi, Alessandra Pecorelli, Cinzia Signorini
2012-09-01

Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome

Alan K. Percy, Jeffrey L. Neul, Daniel G Glaze
2012-02-01

A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome
2012-02-01

Variant of Rett syndrome and CDKL5 gene: clinical and autonomic description of 10 cases.

Ubaldo Bonuccelli, Fabrizio Bianchi, Giovanni Cioni, Giuseppe Gobbi
2012-11-14

Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene.
2012-05-17

Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms.

Aiden Corvin, Gary J. Donohoe, Michael Gill, Derek W. Morris, Daniela Tropea, Ines Molinos, Graham Little
2011-10-19

Clinical severity and quality of life in children and adolescents with Rett syndrome

Jeffrey L. Neul
2011-10-01

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy

Mark E. S. Bailey
2011-09-08

Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice

Walter E Kaufmann
2011-08-01

Rett syndrome: exploring the autism link

Alan K. Percy
2010-12

Rett syndrome: revised diagnostic criteria and nomenclature

Nadia Bahi-Buisson, Jeffrey L. Neul, John Christodoulou, Alessandra Renieri, Alan K. Percy, Walter E Kaufmann, Daniel G Glaze

Article - wd:Q27337778

Welcome to Inventaire

the library of your friends and communities

learn more